The General Public's Willingness to Pay for Tax Increases to Support Unrestricted Access to an Alzheimer's Disease Medication

Author： Oremus Mark   Tarride Jean-Eric   Raina Parminder   Thabane Lehana   Foster Gary   Goldsmith Charlie H.   Clayton Natasha  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.30, Iss.11, 2012-11, pp. : 1085-1095

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Willingness to pay for asthma linked to disease severity, QOL

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 361, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Questioning willingness to pay

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 592, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Willingness to Pay for Cancer Prevention

By Hunt Timothy L.  

PharmacoEconomics, Vol. 27, Iss. 4, 2009-06 ,pp. : 299-312

Adis International

Access to resources Recommend Favorite

Assessment of the Relationship Between Measures of Disease Severity, Quality of Life, and Willingness to Pay in Asthma

By Zillich A.J.  

PharmacoEconomics, Vol. 20, Iss. 4, 2002-04 ,pp. : 257-265

Adis International

Access to resources Recommend Favorite

Differences in Medication Use in the Alzheimer's Disease Neuroimaging Initiative: Analysis of Baseline Characteristics

By Epstein Noam U.  

Drugs & Aging, Vol. 27, Iss. 8, 2010-08 ,pp. : 677-686

Adis International

Access to resources Recommend Favorite